Perimeter Medical Imaging AI, Inc. (PINK) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the Perimeter Medical Q3 2025 conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press zero for the operator. This call is being recorded today. I would now like to turn the conference over to Stephen Kilmer. Please go ahead. Thank you. Good afternoon, everyone. Let me start by pointing out that this conference call will include four linking statements within the meaning of applicable securities laws. These may include statements regarding the future financial position, business strategy, and strategic goals, commercial activities and timing, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, the potential benefits of our products, including the perimeter S-series OCT, perimeter B series OCT, and perimeter image assist, perimeter's ability to broaden its user base and the expected approval of its proprietary AI, expectations regarding new products and the timing thereof, and expectations regarding opportunities for market expansion. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond our control, including the risks and uncertainties described from time to time in our public filings and press releases. which are posted on CDAR+, which are posted on CDAR+. Our results may differ materially from those projected on today's call. No forward-looking statement can be guaranteed. Permit Archer takes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future event...